- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04081649
Cerebral Oxygenation and Neurological Functioning After Cardiac Surgery (CONFUSE)
December 19, 2023 updated by: Dr. Gordon Boyd
The overall goal of this research program is to determine quantitative predictors of quantitative long-term neurological functioning following different cardiac surgery procedures.
The investigators aim to generate a timeline of neurological function that includes pre-existing performance, post-operative delirium, and neurological outcome.
Furthermore, the investigators will test the hypothesis that intraoperative regional cerebral oxygenation (rSO2) desaturations, as measured by near-infrared spectroscopy (NIRS) are associated with poor neurological functioning following cardiac surgery, as measured by a robotic device called the KINARM.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
95
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: J. Gordon Boyd, MD, PhD
- Phone Number: 6135392754
- Email: 2jgb1@queensu.ca
Study Locations
-
-
Ontario
-
Kingston, Ontario, Canada, K7L3V7
- Recruiting
- Kingston General Hospital
-
Contact:
- John G Boyd, MD, PhD
- Phone Number: 6228 613-549-6666
- Email: 2jgb1@queensu.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patient undergoing non-emergent surgery will be recruited from the perioperative assessment clinic by a trained researcher.
Description
Inclusion Criteria:
- adult patients undergoing coronary artery bypass surgery +/- valvular surgery
Exclusion Criteria:
- pre-existing cognitive impairment or neurodegenerative condition
- any reason that participant cannot participate in follow up (lives too far away, limb amputation, speaks language other than english)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Cardiac surgery
Patients undergoing non-emergent cardiac surgery for coronary bypass graft and/or valvular replacement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
12 month cognitive outcome-Repeatable Battery of Neuropsychological Status (RBANS) Total Scale
Time Frame: 12 months
|
Participants will be assessed with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).
The RBANS assesses 5 cognitive domains (language, visuospatial, immediate memory, delayed memory, and attention).
The individual domain scores are compiled to provide at total cognitive score (Total Scale), which is age-adjusted.
The population normative value is 100 +/- 24 (1.96
SD).
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-visually guided reaching
Time Frame: 12 months
|
This centre-out reaching task assesses basic visuospatial skills and sensorimotor control.
The subject's hand is represented by a white dot.
Each subject is then instructed to bring the white dot quickly and accurately to the red target as they appear on the screen.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-arm position matching
Time Frame: 12 months
|
Patients are instructed to mirror-match the movement and final position of the robot-controlled arm.
This task is performed twice to obtain data on both arms.
Patients will require intact proprioceptive functioning to process information on where their limb is in the horizontal space.
This arm position matching task has been shown to determine the degree of position sense impairment in subjects following stroke.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-reverse visually guided reaching
Time Frame: 12 months
|
This task is presented similarly to the visual guided reaching task.
However, the movement of the white dot is now reversed compared to the movement of the patient's hand.
To successfully complete the task, patients must move their hand away from the target, thereby reaching the red target with the white dot.
This is a more complex reaching task, requiring inhibitory control to not automatically reach towards the red target and a cognitive rule to move the white cursor by moving in the opposite direction.
Visuomotor impairments of this nature have been described in individuals at risk of developing Alzheimer's disease.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-ball on bar
Time Frame: 12 months
|
Patients are instructed to use a virtual bar, generated between their hands, to balance a virtual ball as it appears on the screen.
The subject must then bring the balanced ball on bar to different target locations in virtual space.
This task consists of three levels: 1) ball fixed to bar, 2) ball moves along bar based on bar orientation, 3) ball can roll freely along bar.
This task assesses bimanual motor control.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-object hit
Time Frame: 12 months
|
In this task, the participants' hands are represented by paddles.
Subjects are instructed to hit balls falling down from the top of the screen towards them.
As the task progresses, the balls begin to fall more frequently and increase in speed, making the task gradually more difficult.
This simple task measures sensorimotor function and decision-making.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-object hit and avoid
Time Frame: 12 months
|
This task is similar to the object hit task, where patients use the robot's handles to hit objects falling from the top of the screen towards them.
In this task however, patients are instructed to only hit two target shapes while avoiding all other shapes (i.e distractors).
The Object hit & avoid task therefore requires additional cognitive functions related to attention to identify each shape and inhibitory control to avoid the distractors.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-spatial span
Time Frame: 12 months
|
A series of squares light up on the screen in a particular sequence.
Within a 3-by-4 grid of squares, patients are required to replay the sequence by reaching with their dominant hand to the correct squares.
This task assesses visuospatial working memory, and is similar to the Corsi block-tapping task.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
12 month cognitive outcome-KINARM robotic assessment-trail making
Time Frame: 12 months
|
This task is a quantitative version of the standard pen-and-paper neuropsychological test.
In trailing making part A, patients are instructed to connect the numbers 1 through 25.
The trail making part B task requires subjects to connect the dots by alternating numbers and letters (1-A-2-B-3-C, etc.).
This task assesses executive function related to task switching.
This task is quantified by several parameters (eg.
limb speed, reaction time), which are compiled into an overall task score using the Mahalanobis distance, and further converted to an age-, gender, and handedness matched z-score.
A z-score greater than 1.96 is considered abnormal.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive trajectory (changes in KINARM and RBANS performance from pre-surgery, to 3- and 12-months post-operative)
Time Frame: Pre-operative, 3 months post-operative, and 12-months post-operative
|
This will be assessed with the KINARM robot and the RBANS (described above)
|
Pre-operative, 3 months post-operative, and 12-months post-operative
|
Physiological determinants of rSO2
Time Frame: Intraoperative (3-6 hours)
|
Intraoperative hemodynamic and physiological variables will be collected during the operation (eg.
mean arterial pressure (mmHg), heart rate (beats per minute), peripheral oxygen saturation (%)) to determine the predictors of rSO2.
A linear model will be created to demonstrate the relative contribution each of these predictors has to cerebral oxygenation (rSO2-single outcome variable).
|
Intraoperative (3-6 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: J. Gordon Boyd, MD, PhD, Queen's University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2014
Primary Completion (Estimated)
June 30, 2024
Study Completion (Estimated)
June 30, 2025
Study Registration Dates
First Submitted
June 5, 2019
First Submitted That Met QC Criteria
September 6, 2019
First Posted (Actual)
September 9, 2019
Study Record Updates
Last Update Posted (Actual)
December 26, 2023
Last Update Submitted That Met QC Criteria
December 19, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DMED-1672-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We will be willing to share IPD following the publication of our study in peer reviewed literature.
IPD Sharing Time Frame
Following publication of our study, our data will be available for 5 years.
IPD Sharing Access Criteria
Study PI can be contacted via email for data.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina